Cytotoxic effects of fucoidan nanoparticles against osteosarcoma.

Cytotoxic effects of fucoidan nanoparticles against osteosarcoma.
复制标题

DOI:
10.3390/md11114267
复制
发表时间:
2013-10-30
期刊:
影响因子:
5.4
通讯作者:
Mori N
Mori N
中科院分区:
医学2区
文献类型:
--
作者:
Kimura R;Rokkaku T;Takeda S;Senba M;Mori N

文献摘要

参考文献

被引文献

相似文献

在本研究中,我们通过比较天然岩藻依聚糖和岩藻依聚糖脂质纳米粒子在体外和体内对骨肉瘤的细胞毒性作用,分析了岩藻依聚糖的尺寸依赖性生物活性。体外实验表明,纳米颗粒岩藻依聚糖比天然岩藻依聚糖更有效地诱导骨肉瘤细胞系凋亡。使用异种移植骨肉瘤模型在体内证实了纳米颗粒岩藻依聚糖相对于天然岩藻依聚糖更有效的作用。 Caco-2 细胞转运研究表明,纳米颗粒岩藻依聚糖的渗透性高于天然岩藻依聚糖。纳米颗粒岩藻依聚糖较高的生物活性和优异的生物利用度可用于开发骨肉瘤的新疗法。
In this study, we analyzed the size-dependent bioactivities of fucoidan by comparing the cytotoxic effects of native fucoidan and fucoidan lipid nanoparticles on osteosarcoma in vitro and in vivo. In vitro experiments indicated that nanoparticle fucoidan induced apoptosis of an osteosarcoma cell line more efficiently than native fucoidan. The more potent effects of nanoparticle fucoidan, relative to native fucoidan, were confirmed in vivo using a xenograft osteosarcoma model. Caco-2 cell transport studies showed that permeation of nanoparticle fucoidan was higher than native fucoidan. The higher bioactivity and superior bioavailability of nanoparticle fucoidan could potentially be utilized to develop novel therapies for osteosarcoma.
从甲壳虫冈村甲壳虫中提取的口服岩藻糖素对肿瘤含量小鼠模型中肿瘤生长和存活时间的影响。
DOI: 10.3390/md10102337
发表时间: 2012-10
期刊: Marine drugs
影响因子: 5.4
作者:
Azuma K;Ishihara T;Nakamoto H;Amaha T;Osaki T;Tsuka T;Imagawa T;Minami S;Takashima O;Ifuku S;Morimoto M;Saimoto H;Kawamoto H;Okamoto Y
通讯作者: Okamoto Y
DOI: 10.3748/wjg.v18.i18.2225
发表时间: 2012-05-14
影响因子: 4.3
作者:
Mori, Naoki;Nakasone, Kazunori;Ishikawa, Chie
通讯作者: Ishikawa, Chie
DOI: 10.3390/md9101731
发表时间: 2011
期刊: Marine drugs
影响因子: 5.4
作者:
Fitton JH
通讯作者: Fitton JH
DOI: 10.1128/aem.33.2.319-322.1977
发表时间: 1977-01-01
影响因子: 4.4
作者:
SALYERS, AA;VERCELLOTTI, JR;WILKINS, TD
通讯作者: WILKINS, TD
DOI: 10.1271/bbb.90705
发表时间: 2010-02-01
影响因子: 1.6
作者:
Tokita, Yoshiharu;Nakajima, Katsuyuki;Nagamine, Takeaki
通讯作者: Nagamine, Takeaki